TNF and neoplasm: Similar to TAMs, TANs can shift between an anti-tumoral (N1) and a pro-tumoral (N2) phenotype, and Type I interferons (IFN-α and IFN-β) can promote their differentiation toward the N1 subset, reducing the pro-tumor impact of neutrophil extracellular traps and TNF-α expression [67].